RXL:NYE-ProShares Ultra Health Care (USD)

ETF | Trading--Leveraged Equity |

Last Closing

USD 48.28

Change

0.00 (0.00)%

Market Cap

N/A

Volume

8.40K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-16 )

ETFs Containing RXL

KGHG 4.13 % 0.00 %

N/A

N/A
IEUS iShares MSCI Europe Small.. 0.00 % 0.40 %

N/A

USD 0.09B
SCZ iShares MSCI EAFE Small-C.. 0.00 % 0.39 %

N/A

USD 8.75B
LGWU:F Lyxor Index Fund - Lyxor .. 0.00 % 0.00 %

N/A

N/A
ZPRX:F SSgA SPDR ETFs Europe II .. 0.00 % 0.00 %

N/A

USD 0.23B
ZPRX:XETRA SPDR® MSCI Europe Small .. 0.00 % 0.00 %

N/A

N/A
1388:TSE 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Leveraged Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.76% 76% C+ 89% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.76% 76% C+ 89% A-
Trailing 12 Months  
Capital Gain -5.47% 43% F 27% F
Dividend Return 1.52% 69% C- 28% F
Total Return -3.95% 43% F 25% F
Trailing 5 Years  
Capital Gain 132.56% 45% F 77% C+
Dividend Return 6.26% 34% F 11% F
Total Return 138.83% 42% F 73% C
Average Annual (5 Year Horizon)  
Capital Gain 10.79% 25% F 66% D+
Dividend Return 11.14% 25% F 62% D
Total Return 0.35% 23% F 9% A-
Risk Return Profile  
Volatility (Standard Deviation) 31.28% 97% N/A 33% F
Risk Adjusted Return 35.62% 57% F 49% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.